Search research articles
Contact Us
Filters
Showing results (21-30 of 113) with videos related to
Page
of 12
Sort By:
Clinical Lung Cancer
|
September 24, 2018
Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis
Tiffany M Yu, Carl Morrison, Edward J Gold, et al.
Molecular Carcinogenesis
|
January 5, 2017
P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells
Mahamat Babagana, Sydney Johnson, Hannah Slabodkin, et al.
American Journal of Clinical Pathology
|
February 13, 2003
Direct and indirect immunofluorescence as a diagnostic adjunct in the interpretation of nonneoplastic medical lung disease
Cynthia M Magro, Carl Morrison, Amy Pope-Harman, et al.
Gastroenterology
|
April 27, 2013
MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice
Sathish K R Padi, Qunshu Zhang, Youcef M Rustum, et al.
American Journal of Clinical Pathology
|
July 20, 2007
Pigmented purpuric dermatosis: classification by phenotypic and molecular profiles
Cynthia M Magro, Jochen T Schaefer, A Neil Crowson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
April 23, 2009
Epithelioid sarcoma of the vulva in a 17-year-old pregnant woman
Har Rai, Kunle Odunsi, Joshua Kesterson, et al.
American Journal of Cancer Research
|
November 12, 2021
Multiple functions of the DEAD-box RNA helicase, DDX5 (p68), make DDX5 a superior oncogenic biomarker and target for targeted cancer therapy
Fengzhi Li, Christos Fountzilas, Igor Puzanov, et al.
Archives of Pathology & Laboratory Medicine
|
August 27, 2005
CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites
Lindsey B De Lott, Carl Morrison, Saul Suster, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 17, 2018
Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer
Tiffany M Yu, Carl Morrison, Edward J Gold, et al.
Journal of the National Cancer Institute
|
March 16, 2006
Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer
Yasuhiro Tada, Romulo Martin Brena, Björn Hackanson, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 113) with videos related to
Sort By:
Page
of 12
Clinical Lung Cancer
|
September 24, 2018
Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis
Tiffany M Yu, Carl Morrison, Edward J Gold, et al.
Molecular Carcinogenesis
|
January 5, 2017
P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells
Mahamat Babagana, Sydney Johnson, Hannah Slabodkin, et al.
American Journal of Clinical Pathology
|
February 13, 2003
Direct and indirect immunofluorescence as a diagnostic adjunct in the interpretation of nonneoplastic medical lung disease
Cynthia M Magro, Carl Morrison, Amy Pope-Harman, et al.
Gastroenterology
|
April 27, 2013
MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice
Sathish K R Padi, Qunshu Zhang, Youcef M Rustum, et al.
American Journal of Clinical Pathology
|
July 20, 2007
Pigmented purpuric dermatosis: classification by phenotypic and molecular profiles
Cynthia M Magro, Jochen T Schaefer, A Neil Crowson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
April 23, 2009
Epithelioid sarcoma of the vulva in a 17-year-old pregnant woman
Har Rai, Kunle Odunsi, Joshua Kesterson, et al.
American Journal of Cancer Research
|
November 12, 2021
Multiple functions of the DEAD-box RNA helicase, DDX5 (p68), make DDX5 a superior oncogenic biomarker and target for targeted cancer therapy
Fengzhi Li, Christos Fountzilas, Igor Puzanov, et al.
Archives of Pathology & Laboratory Medicine
|
August 27, 2005
CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites
Lindsey B De Lott, Carl Morrison, Saul Suster, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 17, 2018
Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer
Tiffany M Yu, Carl Morrison, Edward J Gold, et al.
Journal of the National Cancer Institute
|
March 16, 2006
Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer
Yasuhiro Tada, Romulo Martin Brena, Björn Hackanson, et al.
Page
of 12